Target-dosing Anemia Treatments for Patients with Diabetes and Chronic Kidney Disease May Carry Risks
Researchers find that individuals with a poor hemoglobin response to ESAs have a higher risk of death and cardiovascular events.
Source: BWH News - Category: Hospital Management Source Type: news
More News: Anemia | Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Endocrinology | Heart | Urology & Nephrology